We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.LICENSE AGREEMENT BY AND BETWEEN CAMURUS AB AND BRAEBURN PHARMACEUTICALS BVBA SPRL NOVEMBER 14, 2014License Agreement • December 30th, 2016 • Braeburn Pharmaceuticals, Inc. • Pharmaceutical preparations • England
Contract Type FiledDecember 30th, 2016 Company Industry JurisdictionThis License Agreement is made as of the 14th day of November, 2014 (the “Effective Date”) between Camurus AB, a limited liability company organized and existing under the laws of Sweden and having its principal place of business at Ideon Science Park, Sölvegatan 41, SE-223 70 Lund, Sweden (“Camurus”) and Braeburn Pharmaceuticals BVBA SPRL, a private limited company organized and existing under the laws of Belgium and having its principal place of business at Louizalaan 209 A, 1050 Brussels, Belgium (“Braeburn”) (each a “Party” and collectively, the “Parties”).
LICENSE AGREEMENT BY AND BETWEEN CAMURUS AB AND BRAEBURN PHARMACEUTICALS BVBA SPRL NOVEMBER 14, 2014License Agreement • December 9th, 2016 • Braeburn Pharmaceuticals, Inc. • Pharmaceutical preparations • England
Contract Type FiledDecember 9th, 2016 Company Industry JurisdictionThis License Agreement is made as of the 14th day of November, 2014 (the “Effective Date”) between Camurus AB, a limited liability company organized and existing under the laws of Sweden and having its principal place of business at Ideon Science Park, Sölvegatan 41, SE-223 70 Lund, Sweden (“Camurus”) and Braeburn Pharmaceuticals BVBA SPRL, a private limited company organized and existing under the laws of Belgium and having its principal place of business at Louizalaan 209 A, 1050 Brussels, Belgium (“Braeburn”) (each a “Party” and collectively, the “Parties”).